research Acute Telogen Effluvium: A Sequela of COVID-19 Infection
COVID-19 can cause temporary hair loss.
Search
for
Sort by
Research
600-630 / 1000+ resultsresearch Faculty Opinions Recommendation of Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – The 'Gabrin Sign'
research Androgenetic Alopecia May Be Associated With Weaker COVID-19 T-Cell Immune Response: An Insight Into a Potential COVID-19 Vaccine Booster
Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.
research Skin Checks and Skin Cancer Diagnosis in Australian General Practice Before and During the COVID-19 Pandemic, 2011–2020
The COVID-19 pandemic led to fewer skin checks and skin cancer diagnoses in Australia in 2020.
research Indirect Skin Sign of COVID-19 Days: Striae Rubrae
The COVID-19 pandemic led to more young people getting red stretch marks due to lifestyle changes like less activity and quick weight gain.
research COVID-19 Dermatological Manifestations: Results from the Mexican Academy of Dermatology COVID-19 Registry
COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.
research The Incidence of Alopecia Areata in a COVID-19 Vaccinated Population: A Single-Center Review
COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.
research The Effects of the COVID-19 Pandemic on the Dermatology Outpatient Clinic of Aydın Adnan Menderes University Hospital
COVID-19 reduced dermatology visits by 30.4%, with more male patients and increased cases of psoriasis, bullous diseases, and melanoma.
research A Rare Case of Constrictive Pericarditis with Co-Existing Positive COVID-19: Probable Autoimmune or Immunoglobulin Related Disease
An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.
research Trend and Co-Occurrence Network of COVID-19 Symptoms From Large-Scale Social Media Data: Infoveillance Study
Social media data can help track and predict COVID-19 symptoms and trends.
research Severe COVID-19 Infection Predisposes Patients to Greater Burden of Hair Loss
People who had severe COVID-19 are more likely to experience hair loss.
research Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: An Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy with Proxalutamide
Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.
research The Double-Edged Sword of Testosterone’s Role in the COVID-19 Pandemic
Testosterone may influence COVID-19 severity and outcomes.
research Testosterone in COVID-19: An Adversary Bane or Comrade Boon
Testosterone's effects on COVID-19 are unclear and need more research.
research Commonalities Between COVID-19 and Radiation Injury
Some drugs may help treat both COVID-19 and radiation injury.
research Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.
research Clinical Diagnosis of COVID-19: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool Based on a 1,757-Patient Cohort (The AndroCoV Clinical Scoring for COVID-19 Diagnosis)
The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.
research Evaluation of the Relationship Between Favipiravir Use and Telogen Effluvium in COVID-19 Patients
Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.
research Dermatological Manifestations During and After COVID-19: A Narrative Review
COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.
research Effects of Exposure Time to Sun on Hair Fall During Lockdown in Covid Pandemic
Quarantine increased hair fall, especially in young women, with no direct link to short sun exposure.
research Efficacy of QR678 Neo Hair Growth Factor Formulation for the Treatment of Hair Loss in COVID-19-Induced Persistent Telogen Effluvium: A Prospective, Clinical, Single-Blind Study
QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.
research End of Activity of Any Type of Active Welding by Low-Level Laser Therapy (LLLT) Specialized Method
Low-level laser therapy is a safe, painless method that effectively treats acne and improves skin without post-treatment care.
research Low Neutralizing Antibody Titers After Asymptomatic or Non-Severe SARS-CoV-2 Infection Over a 6-Month Assessment Period
People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.
research Ovarian Leydig Cell Tumor: Cause of Virilization in a Postmenopausal Woman
A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.
research A Systematic Review on Drug Re-Profiling/Re-Purposing
The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.
research Time to Loss of Response for Dupilumab in Ophiasis-Pattern Alopecia Areata
Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.
research Ingestion of Minoxidil Associated with Elevated Transaminases in the Absence of Ischemic Hepatitis
Minoxidil ingestion can raise liver enzyme levels.
research Clinical Benefits of Baricitinib Therapy for Severe Alopecia Areata
Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.
research Effectiveness of Short-Term Canrenone Treatment in Idiopathic Hirsutism
Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.
research Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata Over 52 Weeks in Phase III Trials
Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.